Drug
Albuterol Sulfate Inhalation Aerosol
Albuterol Sulfate Inhalation Aerosol: highest development phase Phase 3, developed by Cipla. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Cipla
Trials
| Drug | Phase | Indication |
|---|---|---|
| Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) NCT06154304 | Phase 3 | Bronchial Asthma |
Latest
No recent events.
Follow Albuterol Sulfate Inhalation Aerosol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.